Descripción del proyecto
Cura para las complicaciones neurológicas de la COVID-19
El impacto de las frecuentes complicaciones neurológicas y psiquiátricas resultantes de la infección por coronavirus del síndrome respiratorio agudo grave 2 puede ser devastador a escala pandémica debido a la falta de tratamiento. Por lo tanto, el proyecto NEUROCOV, financiado con fondos europeos, investigará las complicaciones cognitivas y neurodegenerativas asociadas con la COVID-19, el neuroCOVID, utilizando un enfoque interdisciplinario innovador. El objetivo es desarrollar una metodología para anticipar y gestionar vulnerabilidades personalizadas y sus efectos a nivel poblacional. El enfoque general incluirá la epidemiología, la investigación de la interacción virus-hospedador a nivel unicelular y el modelado predictivo para identificar posibles biomarcadores y fármacos que reorientar. El espectro fenotípico del neuroCOVID se obtendrá a través de los principales registros nacionales de salud y tres cohortes clínicas, lo que permitirá el análisis de las complicaciones, los factores de riesgo y la carga socioeconómica.
Objetivo
The COVID19 pandemic has shown our health care fragility vis a vis novel pathogens, with a global disruption on societal welfare. Despite the towering success of vaccine development, lack of preparedness on integrative clinical and molecular phenotyping has emerged with clarity and highlights the need to scale translational efforts for personalized prevention and therapy. Of particular concern are the long-term consequences of SARS-CoV-2 infection with high and rising prevalence of chronic manifestations referred to as Post-COVID. Among these the neurological and psychiatric complications stand out for frequency, lack of treatment and devastating impact of their effects at pandemic scale. Here, we tackle the cognitive and neurodegenerative complications of COVID-19, referred to as NeuroCOVID, as a ticking pandemic within the pandemic that requires an innovation leap across disciplines. We pursue a multi scalar approach that reaches from epidemiology and mechanistic interrogation of host/virus interplay at single cell resolution through predictive modelling all the way to validation of biomarkers and repurposed drugs. The aim is to anticipate and effectively manage personalized trajectories of NeuroCOVID vulnerability and their impact at population level. For this we leverage two leading national health registries and three clinical cohorts to characterize the phenotypic spectrum of NeuroCOVID, its risk factors and its socioeconomic burden at high definition. We pioneer innovative robotics to scale brain organoid modelling and combine it with single cell multiOMICs and AI analytics to dissect the principles of the individual host response and render experimentally actionable the authentic genetic backgrounds of differential SARS-CoV-2 sensitivity. Through a substantive engagement of patients’ collectives and health care stakeholders, upstream integration of innovative pipelines streamlines translation and operationalizes precision medicine for emerging medical needs.
Ámbito científico
- natural sciencesbiological sciencesmicrobiologyvirology
- medical and health scienceshealth sciencespublic healthepidemiologypandemics
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines
- medical and health scienceshealth sciencespersonalized medicine
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringrobotics
Palabras clave
Programa(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaRégimen de financiación
HORIZON-RIA - HORIZON Research and Innovation ActionsCoordinador
53127 Bonn
Alemania